The health economic benefits to individual substance users and to society of substance use disorder (SUD) treatment and hepatitis C (HCV) and HIV treatment of substance users need to be evaluated and communicated to decision makers in terms that are relevant to the diverse systems in which care is delivered. Researchers need better support, including skills and infrastructure, to effectively disseminate their economic findings in the evolving health policy environment. The overall aim of CHERISH (Center for Health Economics of TReatment Interventions for Substance Use Disorder, HCV, and HIV) is to develop and disseminate economic evidence that informs substance use treatment policy and HCV and HIV care of substance users, and to increase the impact of this research by addressing the needs of integrated healthcare system providers and payers. In support of this aim, the CHERISH Dissemination and Policy Core will have a unique combination of expertise in the theory and practice of dissemination research, understanding of national health economic policy both broadly and specifically relating to treatment of SUD and related conditions, clinical experience in SUD treatment, and experience identifying and convening stakeholders and engaging them in constructive dialogue with health economics researchers. The Policy and Dissemination Core?s specific aims are 1) to translate and disseminate health economic research results to key stakeholders for SUD, HCV, and HIV treatment decisions, and 2) to enhance the relevance and impact of Center research by assessing stakeholder needs for economic information on SUD, HCV, and HIV treatment of substance users and by working with researchers to refine the relevance of their research and findings. We will repackage research results for target policy audiences and push this content through traditional and new media channels, and we will develop a network of relevant stakeholders and share content through stakeholder conferences, face-to- face meetings, and policy roundtables. We will conduct an in-depth assessment of the needs of decision makers for economic information to make informed SUD, HCV, and HIV treatment decisions. Based on the needs identified, we will work with Center researchers to anticipate the specific policy relevance of their results while their research is in progress in order to plan for dissemination of their findings and design future research. We will work with the Methodology Core to assist it in promoting economic evaluation methods, translating these methods for decision makers, and promoting harmonization of economic data collection tools. We will work closely with the HCV and HIV Core to disseminate and translate the results of HCV and HIV longitudinal data analyses and simulation modeling. We will collaborate with the Pilot Grant and Training Core to evaluate and mentor pilot projects relating to dissemination science, to provide intensive training and mentoring of pilot grant awardees, and to conduct introductory in-person and web-based training in dissemination methods and practices.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA040500-05
Application #
9692586
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
2020-11-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Leech, Ashley A; Burgess, James F; Sullivan, Meg et al. (2018) Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States. AIDS 32:2787-2798
Behrends, Czarina N; Nugent, Ann V; Des Jarlais, Don C et al. (2018) Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. J Acquir Immune Defic Syndr 79:e76-e78
Oluwoye, Oladunni; Skalisky, Jordan; Burduli, Ekaterina et al. (2018) Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness. Contemp Clin Trials 69:92-98
Akiyama, Matthew J; Agyemang, Linda; Arnsten, Julia H et al. (2018) Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy. BMC Infect Dis 18:74
Assoumou, Sabrina A; Tasillo, Abriana; Leff, Jared A et al. (2018) Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis 66:376-384
Murphy, Sean M; McCollister, Kathryn E; Leff, Jared A et al. (2018) Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse. Ann Intern Med :
Miclette, Matthew A; Leff, Jared A; Cuan, Isabella et al. (2018) Closing the gaps in opioid use disorder research, policy and practice: conference proceedings. Addict Sci Clin Pract 13:22
Zhang, Yongkang; Johnson, Phyllis; Jeng, Philip J et al. (2018) First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults. J Gen Intern Med :
Behrends, Czarina N; Eggman, Ashley A; Gutkind, Sarah et al. (2018) A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination. J Public Health Manag Pract :
Linas, Benjamin P; Nolen, Shayla (2018) A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am 32:447-459

Showing the most recent 10 out of 93 publications